This photograph shows a sign reading "INSERM" indicating the entrance to the Inserm ART-RNAm laboratory of the CHR (Regional Hospital Centre), in Orleans, central France, on November 18, 2025. Researchers at Inserm are working to develop new treatments for numerous diseases using messenger RNA, which became widely known to the public through the vaccines developed against COVID-19, particularly to combat pancreatic cancer, one of the most aggressive forms. (Photo by JEAN-FRANCOIS MONIER / AFP) (Photo by JEAN-FRANCOIS MONIER/AFP via Getty Images)